Immunotherapy in Glioblastoma: An Overview of Current Status

Zouina Sarfraz,1 Arun Maharaj,1 Vyshak Alva Venur,2 Justin D Lathia,3 Yazmin Odia,1 Manmeet S Ahluwalia1,4 1Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA; 2Seattle Cancer Care Alliance, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA; 3Cleveland Clini...

Full description

Bibliographic Details
Published in:	Clinical Pharmacology: Advances and Applications
Main Authors:	Sarfraz Z, Maharaj A, Venur VA, Lathia JD, Odia Y, Ahluwalia MS
Format:	Article
Language:	English
Published:	Dove Medical Press 2025-07-01
Subjects:	Glioblastoma immunotherapy tumor microenvironment antigen heterogeneity personalized treatment blood-brain barrier.
Online Access:	https://www.dovepress.com/immunotherapy-in-glioblastoma-an-overview-of-current-status-peer-reviewed-fulltext-article-CPAA

Similar Items

Editorial: Immunosuppression mechanisms and immunotherapy strategies in glioblastoma
by: Sihan Xiong, et al.
Published: (2024-04-01)

Biophysical Control of the Glioblastoma Immunosuppressive Microenvironment: Opportunities for Immunotherapy
by: Landon Teer, et al.
Published: (2024-01-01)

Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges
by: Frontiers Production Office
Published: (2021-10-01)

Combining immunotherapy with radiotherapy for glioblastoma: recent advances and challenges
by: Yuanyang Sun, et al.
Published: (2025-05-01)

The immunosuppressive microenvironment and immunotherapy in human glioblastoma
by: Xuehua Zhang, et al.
Published: (2022-11-01)

Immunotherapy of Glioblastoma: Current Strategies and Challenges in Tumor Model Development
by: Bernarda Majc, et al.
Published: (2021-01-01)

Spatial organization of heterogeneous immunotherapy target antigen expression in high-grade glioma
by: Michael E. Barish, et al.
Published: (2022-08-01)

The hotspots and publication trends in glioblastoma and CAR-T immunotherapy: A bibliometric analysis
by: Zhaoming Song, et al.
Published: (2025-12-01)

Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches
by: Dev Kumar Tripathy, et al.
Published: (2024-03-01)

Developing and validating a prognostic disulfidptosis-related signature for glioblastoma: predicting radioresistance and synergestic effect with immunotherapy
by: Chen Chen, et al.
Published: (2025-03-01)

Immunotherapy of glioblastoma: Recent advances and future prospects
by: Boyang Yuan, et al.
Published: (2022-11-01)

Prospects of immune checkpoint blockade and vaccine-based immunotherapy for glioblastoma
by: Tietze Stefanie, et al.
Published: (2021-04-01)

Enhancing T cell infiltration in glioblastoma: a review article on challenges and therapeutic strategies
by: Mohammad Amin Habibi, et al.
Published: (2025-01-01)

Targeting tumor-associated macrophages for the immunotherapy of glioblastoma: Navigating the clinical and translational landscape
by: Zide Wang, et al.
Published: (2022-10-01)

Updates in Glioblastoma Immunotherapy: An Overview of the Current Clinical and Translational Scenario
by: Andrea Bianconi, et al.
Published: (2023-05-01)

Exploiting Radiation Therapy to Restore Immune Reactivity of Glioblastoma
by: Mara De Martino, et al.
Published: (2021-05-01)

TERT mutations-associated alterations in clinical characteristics, immune environment and therapy response in glioblastomas
by: Feng Tang, et al.
Published: (2023-08-01)

Emerging insights into the immunosuppressive tumor microenvironment and its implications for glioblastoma immunotherapy
by: Niovi Nicolaou, et al.
Published: (2025-10-01)

Why Do Glioblastoma Treatments Fail?
by: Alen Rončević, et al.
Published: (2025-02-01)

Understanding the glioblastoma tumor microenvironment: leveraging the extracellular matrix to increase immunotherapy efficacy
by: Jimena Collado, et al.
Published: (2024-02-01)

Integrative multi-omic profiling of the neoantigen landscape of glioblastoma for the development of therapeutic vaccines reveals vast heterogeneity in immunogenic signatures
by: Qingtang Lin, et al.
Published: (2025-03-01)

Cell-based and cell-free immunotherapies for glioblastoma: current status and future directions
by: Mingming Wang, et al.
Published: (2023-05-01)

Chimeric Exosomes Functionalized with STING Activation for Personalized Glioblastoma Immunotherapy
by: Peng Bao, et al.
Published: (2024-02-01)

Decoding of the surfaceome and endocytome in primary glioblastoma cells identifies potential target antigens in the hypoxic tumor niche
by: Kelin Gonçalves de Oliveira, et al.
Published: (2024-02-01)

Glioblastoma vaccine tumor therapy research progress
by: Tong Zhao, et al.
Published: (2022-01-01)

Labeling T Cells to Track Immune Response to Immunotherapy in Glioblastoma
by: John Y. Rhee, et al.
Published: (2023-01-01)

Tumor antigens and immune subtypes of glioblastoma: the fundamentals of mRNA vaccine and individualized immunotherapy development
by: Changwu Wu, et al.
Published: (2022-07-01)

Prognostic values and immune infiltration of KLF15, AQP7, AGPAT9 in glioma and glioblastoma
by: Ayobami Matthew Olajuyin, et al.
Published: (2024-03-01)

The advances in targeted therapy and immunotherapy for glioblastoma: Basic research and clinical trials
by: Mei Wang, et al.
Published: (2018-01-01)

γδ T cells as a potential therapeutic agent for glioblastoma
by: In Kang, et al.
Published: (2023-10-01)

Myeloidcells in the immunosuppressive microenvironment in glioblastoma: The characteristics and therapeutic strategies
by: Boyuan Huang, et al.
Published: (2023-02-01)

Advances in Cellular Immune Theranostic Approaches for Glioblastoma: Current Trends and Future Directions
by: Ying Gong, et al.
Published: (2025-08-01)

Neoadjuvant PD-1 blockade induces the autophagy of immune cells: a new target for synergistic therapy of recurrent glioblastoma
by: Zixue Xuan, et al.
Published: (2025-09-01)

Hypoxia within the glioblastoma tumor microenvironment: a master saboteur of novel treatments
by: Lisa Feldman
Published: (2024-06-01)

Vaccination in the immunotherapy of glioblastoma
by: Ziren Kong, et al.
Published: (2018-02-01)

Biomimetic nanoparticles directly remodel immunosuppressive microenvironment for boosting glioblastoma immunotherapy
by: Tingting Wang, et al.
Published: (2022-10-01)

Translational landscape of glioblastoma immunotherapy for physicians: guiding clinical practice with basic scientific evidence
by: Daniel Kreatsoulas, et al.
Published: (2022-06-01)

Laser Capture Microdissection and RNA-Seq Analysis: High Sensitivity Approaches to Explain Histopathological Heterogeneity in Human Glioblastoma FFPE Archived Tissues
by: Prospero Civita, et al.
Published: (2019-06-01)

Overcoming T-cell exhaustion in glioblastoma: A narrative review
by: Xuya Wang, et al.
Published: (2022-01-01)

Inhibiting interferon-γ induced cancer intrinsic TNFRSF14 elevation restrains the malignant progression of glioblastoma
by: Yunhe Han, et al.
Published: (2024-07-01)